Calcium carbonate and Hair loss for Women aged 60+ (a phase IV clinical study of FDA data)
Summary:
Hair loss is found for women aged 60+ who take Calcium carbonate (calcium). This study is created by eHealthMe based on reports of 4,198 women aged 60+ from the FDA, and is updated regularly. The information that eHealthMe analyzes includes:
- Time on Calcium carbonate when people have Hair loss
- Top conditions
- Top co-used drugs
- Top other side effects
4,198 women aged 60+ reported to have side effects when taking Calcium carbonate.
Among them, 96 people (2.29%) have Hair loss
What is Calcium carbonate?
Calcium carbonate has active ingredients of calcium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 16,045 Calcium carbonate users. Check the latest studies of Calcium carbonate.
What is Hair loss?
Hair loss is found to be associated with 2,411 drugs and 3,514 conditions by eHealthMe. Check the latest studies of Hair loss.
Number of reports submitted per year:

Time on Calcium carbonate when people have Hair loss *
- < 1 month: 83.33 %
- 1 - 6 months: 16.67 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Severity of Hair loss
n/aHow people recovered from Hair loss
n/aTop conditions involved for these people *:
You may use this to check any potential undetected conditions.
- Pain: 41 people, 42.71%
- Dyspnea (difficult or laboured breathing): 36 people, 37.50%
- Urinary Tract Infection: 29 people, 30.21%
- Back Pain: 29 people, 30.21%
- Breast Cancer: 29 people, 30.21%
- Ejection Fraction Decreased (systolic heart failure): 29 people, 30.21%
- Pleural Effusion (water on the lungs): 29 people, 30.21%
- Breast Cancer Metastatic: 24 people, 25.00%
- Diarrhea: 18 people, 18.75%
- Nausea (feeling of having an urge to vomit): 15 people, 15.62%
Top co-used drugs for these people *:
You may use this to check any potential interacting drugs.
- Acetaminophen: 46 people, 47.92%
- Ondansetron: 44 people, 45.83%
- Chlorpheniramine Maleate: 39 people, 40.62%
- Dexamethasone: 39 people, 40.62%
- Prednisolone: 38 people, 39.58%
- Lisinopril: 34 people, 35.42%
- Furosemide: 33 people, 34.38%
- Anastrozole: 32 people, 33.33%
- Ramipril: 31 people, 32.29%
- Digoxin: 31 people, 32.29%
Top other side effects for these people *:
You may use this to check any potential undetected side effects.
- Diarrhea: 57 people, 59.38%
- Fatigue (feeling of tiredness): 57 people, 59.38%
- Nausea (feeling of having an urge to vomit): 52 people, 54.17%
- Dizziness: 51 people, 53.12%
- Dyspnea (difficult or laboured breathing): 42 people, 43.75%
- Back Pain: 37 people, 38.54%
- Weight Decreased: 36 people, 37.50%
- Headache (pain in head): 36 people, 37.50%
- Constipation: 34 people, 35.42%
- Pleural Effusion (water on the lungs): 31 people, 32.29%
* Approximation only. Some reports may have incomplete information.
Do you take Calcium carbonate and have Hair loss?
- Check whether Hair loss is associated with a drug or a condition- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies:
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
- Lindsey SF, Tosti A, "Hair loss induced by tumor necrosis factor alpha inhibitors", J Clin Investigat Dermatol, 2015 Jan .
Related studies:
How the study uses the data?
The study is based on (applicable) gender, age, calcium (the active ingredients of Calcium carbonate) and Calcium carbonate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Spravato cause Rashes? - 42 seconds ago
- Could Euthyrox cause Dactylitis? - 43 seconds ago
- Zopiclone vs. Catapres, side effect and effectiveness comparison - 44 seconds ago
- Neuralgia and drugs of ingredients of gemcitabine - 50 seconds ago
- Could Asacol cause Upper Respiratory Tract Infection? - 57 seconds ago
- Could Stelara cause Aseptic Necrosis? - a minute ago
- Aneurysm and drugs of ingredients of clopidogrel - a minute ago
- Could Mifepristone cause Death? - a minute ago
- Face Oedema and drugs of ingredients of aliskiren hemifumarate - a minute ago
- Drug interactions of Zofran and Tigan - a minute ago